Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | STX-001 |
Synonyms | |
Therapy Description |
STX-001 is a self-replicating mRNA encoding the cytokine IL-12, which potentially enhances antitumor immune response (Cancer Res (2023) 83 (7_Supplement): 2731). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
STX-001 | STX 001|STX001 | STX-001 is a self-replicating mRNA encoding the cytokine IL-12, which potentially enhances antitumor immune response (Cancer Res (2023) 83 (7_Supplement): 2731). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06249048 | Phase Ib/II | Pembrolizumab + STX-001 STX-001 | Phase 1/2 Study of IT STX-001 in Patients With Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab | Recruiting | USA | AUS | 0 |